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Abstract 
Salmon farming has expanded dramatically in recent years, increasing the demand for 
both traditional feed ingredients and alternative proteins and oils. Developing new 
feed requires a deep understanding of appetite, feed intake, growth, and physiology in 
Atlantic salmon Salmo salar. Regulation of appetite involves interactions between 
peripheral signals and the brain that influence feed intake and metabolism. The brain 
and primarily the hypothalamus produce orexigenic or anorexigenic neuropeptides 
that inhibit or stimulate food intake. Feed intake can also be affected by peripheral 
hormones, such as leptin and ghrelin. In this study individual Atlantic salmon were 
placed in tanks and feed intake was monitored until feed intake stabilized, after which 
each individual was injected intraperitoneally with recombinant salmon LEPA1 or 
rainbow trout Oncorhynchus mykiss GHRL1 emulsified in vegetable oil. Feed intake 
was monitored for a further four days after which fish were removed 4 hours after 
feeding for sampling. Brain, liver and stomach samples were taken for QPCR analysis 
of appetite related genes. Plasma samples were analysed for ghrelin, triglycerides, 
glucose, free fatty acids, lactate and D-3-Hydroxybutyrate. This study reports that 
administered rsLEPA1 causes a significant reduction in feed intake and SGR in 
Atlantic salmon. POMCA1 and POMCA2 expression in brain was only upregulated in 
fish with a significant reduction in feed intake and we suggest that POMC expression 
is linked to appetite reduction. Hepatic LEPA1 and LEPA2 mRNA expression was 
upregulated in rsLEPA1 administered fish which also showed a reduction in feed 
intake and growth, therefore we suggest that hepatic expression of LEP isoforms are 
linked to metabolism. PYY mRNA expression was down-regulated in brain tissue in 
fish with a significant reduction in feed intake and could be involved in the leptin-
signaling pathway at a central level. Significantly higher mRNA expression of 
GHRL1A and GHRLIB was found in the stomach of rtGHRL administered fish 
compared to control, and mRNA expression of both genes was only up-regulated 
when plasma ghrelin levels were found to be elevated. Rainbow trout GHRL1 
administered IP was not found to affect feed intake in Atlantic salmon in this study. 
CCKL and CCKN mRNA expression was downregulated in the brain tissue of 
rtGHRL administered fish which also showed elevated plasma ghrelin levels. 
Furthermore we have validated a method incorporating an individual based system 
and IP administration of hormones with minimal stress on fish which allows Atlantic 
salmon to resume feeding within hours of being returned to the tanks.   
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1. Introduction 
 
1.1 General background  
The salmon farming industry has expanded dramatically during the past few decades, 
thus the demand for feed and major feed ingredients such as fishmeal and fish oil 
have risen (Waagbo et al., 2001). Marine feed ingredients are a limited resource and 
have become increasingly expensive as supplies have diminished, which has resulted 
in the increased use of alternative proteins and oils, such as soybean meal or rapeseed 
oil in the fish feed industry (Carter and Hauler, 2000, Bell et al., 2002). The use of 
alternative oils and proteins into feed requires that developers of new feed have a 
deep understanding of how plant based ingredients may interact with and affect the 
appetite, feed intake, growth and physiology of Atlantic salmon Salmo salar (Sissener 
et al. 2013; Hevrøy et al. 2008).  
 
The regulation of appetite is a complex process involving a number of interactions 
between peripheral signals and the brain, these signals influence metabolism and 
determine growth in vertebrates, including Atlantic salmon (Volkoff et al., 2005). The 
brain, primarily the hypothalamus produces orexigenic or anorexigenic neuropeptides 
that inhibit or stimulate food intake respectively (Volkoff et al., 2005). Feed intake is 
also affected by external factors such as environment, season, time of day, availability 
of food, and stress, or internal factors such as circulating levels of glucose or 
hormones such as leptin and ghrelin (Hoskins and Volkoff, 2012). The nervous 
system, gastrointestinal (GI) tract, adipose tissue and external environment mediate 
afferent signals that are involved in maintaining energy homeostasis (Valen et al., 
2011). A number of studies have dealt with the effects of external factors such as 
photoperiod, temperature and stress on the appetite and feed intake of Atlantic 
salmon, however the knowledge of neuropeptides and their role in appetite regulation 
is still limited (Volkoff et al., 2005). In terms of optimizing and developing feed for 
farmed aquaculture species such as Atlantic salmon it is important to understand the 
processes that regulate feed intake, metabolism and growth. As knowledge of 
neuropeptides and their influence on the regulation of feed intake and metabolism in 
teleosts is limited, it is very important  to focus on this area of research. In vertebrates 
hormones produced by the brain and peripheral organs that regulate feeding behaviour 
and food intake are defined as appetite regulating hormones (Hoskins and Volkoff, 
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2012). These include appetite stimulators or orexigenic factors such as ghrelin, 
neuropeptide Y (NPY), agouti-related peptide (AGRP) and appetite inhibitors or 
anorexigenic factors such as leptin, cocaine and amphetamine regulated transcript 
(CART), pro-opiomelanocortin (POMC) and cholecystokinin (CCK). Leptin and 
ghrelin specifically are peptide hormones with key regulatory effects on feed intake 
and energy homeostasis in mammals (Murashita et al., 2008; Kaiya et al., 2008). 
Further investigation of these hormones and their effects in teleosts will increase the 
understanding of how feed intake and appetite is regulated in an economically very 
important aquaculture species, such as the Atlantic salmon.   
 
1.2 Leptin 
Leptin is a 16-kDa protein hormone belonging to the class-1 helical cytokine family 
of proteins (Trombley et al., 2012). Leptin was first discovered in the mouse Mus 
musculus by Zhang et al., (1994) and has a central role in the regulation of appetite, 
energy metabolism, body composition, immune functions and reproduction in 
mammals (Trombley et al., 2012, Pelleymounter et al., 1995, Barb et al., 2001, 
Leininger et al., 2009, Miller et al., 2002, Yu et al., 1997, Amstalden et al., 2002). 
Leptin is primarily produced in adipose tissue and is secreted into the blood stream 
after cleavage of the 21 amino acid signal peptide (Barb et al., 2001), secretion occurs 
in response to changes in body fat levels or energy status (Zhang et al., 1994, Barb et 
al., 2001). Leptin acts as an anorexigenic signal through a negative feedback loop to 
the appetite centre in the hypothalamus causing long term and short-term effects on 
feed uptake and energy homeostasis (Trombley et al., 2012). Elevated plasma leptin 
levels inhibit continued feeding and regulate body weight in the long term as well as 
promoting postprandial satiety (Trombley et al., 2012). Low leptin levels are 
associated with low body fat levels and starvation (Kolaczynski et al., 1996), 
signaling energy insufficiency and stimulating appetite in humans (Dardeno et al., 
2010) rats Rattus spp. (Shiraishi et al., 2000) and pigs Sur spp. (Ramsay et al., 2004). 
The leptin gene is highly conserved across mammalian species, and the mouse Mus 
spp. protein exhibits 83% homology with human Homo sapiens leptin (Zhang et al., 
1994). The gene contains three exons, separated by two introns (Green et al., 1995).  
 
In teleosts, leptin was first discovered by Kurokawa et al., (2005), who identified a 
cDNA coding homologue to mammalian leptin in the pufferfish Takifugu rubripes. 
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Phylogenetic analysis revealed that the degree of amino acid (aa) conservation was 
low between fish and higher vertebrates, with only 13.2% sequence identity between 
pufferfish and the human sequence. Leptin has since been described in a number of 
teleost species such as; Atlantic salmon, rainbow trout Oncorhynchus mykiss, Striped 
bass Morone saxatilis, Orange-spotted grouper Epinephelus coioides, Grass carp 
Ctenopharyngodon idellus and Yellow catfish Pelteobagrus fulvidraco. (Ronnestad et 
al., 2010; Murashita et al., 2008; Won et al., 2012; Zhang et al., 2013; Li et al., 2010; 
Gong et al., 2013). Leptin in teleost species generally shows low aa identity between 
species and with human leptin, LEP in striped bass for example is 52% homologous 
to LEP in Atlantic salmon LEP and 46% homologous to the human LEP sequence 
(Won et al., 2012).  
 
 
The first study on Atlantic salmon identified two paralogues for leptin, LEPA1 and 
LEPA2, where the 171 aa sequence for LEPA1 and 175 aa sequence for LEPA2 shared 
71,6% identity with each other and 22,4% and 24.1% identity to human leptin, 
respectively (Rønnestad et al., 2010). Recently, Angotzi et al., (2013) also identified 
LEPB duplicated leptin genes in Atlantic salmon, which have 98% aa identity 
between LEPB variants. As mentioned leptin belongs to the class-1 helical cytokine 
family, which possesses a distinctive α-helix bundle in the 3D structure, this tertiary 
structure is generally conserved throughout leptin orthologs across species. Leptin in 
pufferfish and Atlantic salmon both closely resemble mammalian leptin in structure 
based on in silico analysis (Kurokawa et al., 2005; Rønnestad et al., 2010). Later 
Angotzi et al., (2013) examined the structure of LEPB and found it too was a four 
helical cytokine and that the basic structural pattern of the protein was similar to that 
of human leptin and leptin orthologs in other teleost species. LEPB has also been 
found in japanese medaka Oryzias latipes (Kurokawa and Murashita, 2009), zebrafish 
Danio rerio (Gorissen et al., 2009) and Orange spotted grouper (Zhang et al., 2013).  
 
In teleosts leptin is expressed in a variety of tissues and there is much variation in 
areas of expression between species and variation in the expression of the different 
leptin orthologues. Unlike mammals the major site of leptin expression in Pufferfish, 
rainbow trout and Atlantic salmon is the liver (Kurokawa et al., 2005, Murashita et 
al., 2008, Kling et al., 2012, Trombley et al., 2012). Won et al., 2012 found that 
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mRNA expression of leptin occurred solely in the liver of Striped bass and suggest 
that the liver is the major site of leptin production in bass and other teleosts. Gong et 
al., (2013) found that LEP was expressed in a wide range of tissues but the highest 
levels of expression were found in the liver of yellow catfish. Rønnestad et al., (2010) 
found that LEPA1 and LEPA2 were expressed in a range of tissues and organs in 
Atlantic salmon although at very low levels. The highest mRNA levels of LEPA1 
were observed in the brain, however white muscle; liver and ovaries also had high 
expression. mRNA levels of LEPA2 where generally found to be lower than LEPA1 
except in the stomach, midgut and kidney (Rønnestad et al., 2010). The multiple 
expression sites for the different orthologues indicate that leptin may have multiple 
roles in Atlantic salmon. However the identification of high LEPA2 expression in the 
stomach is concurrent with results in mammals, as leptin is also produced in the 
stomach and released into the gastric juice following a meal, and it is suggested that 
leptin may act in regulating the absorptive capacity for nutrients in the intestine, 
thereby indirectly affecting energy homeostasis (Rønnestad et al., 2010). In Atlantic 
salmon specifically there are varying results in terms of the main site of expression, 
Trombley et al., (2012) found that LEPA1 and LEPA2 genes were mainly expressed 
in the liver of juvenile Atlantic salmon. Furthermore Kling et al., (2012) also found 
highest levels of LEPA1 expression in the liver of juvenile rainbow trout. However 
life history stage may influence the level of different isoforms of LEP expression in a 
given region of the body. 
  
In mammals, leptin informs the hypothalamus (Baskin et al., 1998; Barb et al., 2001) 
about the amount of fat stored in the body through short and long forms of leptin 
receptor, LEPR (Roubos et al., 2012). Six LEPR mRNA transcripts that produce 
various LEPR protein isoforms have been identified in mammals (Zabeau et al., 2003, 
Roubos et al., 2012).  According to Robertson et al., (2008) the isoform LEPRB has 
no enzymatic activity but propagates downstream leptin signals through LEPRB 
associated tyrosine kinase JAK2. In mammals LEPRB expressing neurons mediate 
leptin action and different brain centres elicit different responses, the hindbrain is in 
control of satiety along with the hypothalamus, but the hypothalamus also controls 
glycemic, thyroid, reproductive functions by leptin signaling through LEPRB and 
JAK2 pathway. In fish LEPR and the associated leptin receptor overlapping transcript 
(LEPROT) are found mostly in the pituitary rather than the hypothalamus as is 
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common in mammalian counterparts and physiological actions of leptin are mediated 
the membrane bound leptin receptors or LEPR (Rønnestad et al., 2010, Gong et al., 
2013). The anorexigenic effects of leptin are mostly mediated through the neurons 
expressing the long isoform of LEPR (Robertson et al., 2008). A leptin receptor 
ortholog has also been identified in Atlantic salmon (Rønnestad et al., 2010), with 
24,2% amino acid sequence similarity to human LEPR, however Atlantic salmon is a 
tetraploid species as the genome has been duplicated at some point in its life history 
and it has two LEPR genes (Rønnestad et al., 2010). In yellow catfish only one copy 
of the LEPR gene has been discovered (Gong et al., 2013). Atlantic salmon LEPR is 
also highly expressed in tissues such as the brain, eye, gill and visceral adipose tissue 
(Rønnestad et al., 2010). By further examining the expression of LEPA1, LEPA2, 
LEPR1 and LEPR2 in stomach, liver and brain tissue, it may be possible to shed light 
on the signaling pathways of leptin and describe what effects this signaling pathway 
may have on the regulation of appetite and metabolism in Atlantic salmon. 
 
In teleosts including Atlantic salmon it is unclear how the leptin systems are 
influenced by tissue-specific energy status as data on leptin in teleosts is to scarce to 
allow a generalization (Rønnestad et al., 2010). One approach to exploring the 
physiological role of leptin has been to analyse plasma leptin levels during periods of 
feeding and fasting and in fish fed different amounts of feed. Trombley et al., (2012) 
found an increase in LEPA1 expression and higher levels of plasma leptin in feed 
restricted fish, while LEPA2 expression decreased in feed restricted and normal fed 
fish, and suggest that LEPA1 and leptin plasma levels behave in an opposite way to 
that observed in mammals. These findings are supported by Kling et al., (2009) who 
found that plasma leptin was elevated in rainbow trout during fasting, and suggest that 
the relation between circulating leptin levels and energy status differs from mammals; 
in cows for example fasting causes a decrease in leptin plasma concentrations 
(Chelikani et al., 2004). Kling et al., (2012) found that feed restriction causes an 
upregulation of the LEPA1 gene expression as well as an increase of plasma leptin, 
and state that liver-derived leptin reflects plasma levels. Furthermore Kling et al., 
(2009, 2012) proposed that leptin is linked to energy balance, but that it may not act 
as an adiposity signal in salmonids, which could point to a functional divergence 
between ectothermic and endothermic vertebrates. On the other hand Tinoco et al., 
(2012) could find no correlation between nutritional status and the leptin system in 
  14 
goldfish, Carassius auratus, and suggested that leptin may signal short term changes 
in food intake but seem to operate independently of fasting and overfeed conditions. 
 
Rønnestad et al., (2010) reported that Atlantic salmon fed on a moderately restricted 
feeding regime (60%) resulted in lower growth and lower LEPA1 expression in the 
main lipid storing tissues. Furthermore they found central effects of plasma leptin on 
energy homeostasis acting through LEPR in the brain, as Atlantic salmon fed on 
rationed diets showed lower LEPR expression in the brain than fully fed fish. These 
results suggest that regulation of LEPR at the level of the brain may form part of the 
regulatory system for leptin on energy homeostasis in line with the mammalian 
model. Re-evaluation of the method used for qPCR assay of LEPA1 in this study may 
however question the validity of this result and this should be reassessed in a new 
study (Rønnestad et al., unpublished data) 
 
The large variability in the AA sequence between teleosts and humans leads to the 
question to what extent the function of leptin is conserved across species, although a 
conserved 3D structure indicates similarities. Leptin may play a different role in the 
regulation of physiological functions compared with their endothermic mammalian 
counterparts. It is important to further examine the possible multiple physiological 
functions of leptin in order to have a better understanding of the underlying 
mechanisms that control the metabolic physiology of teleosts 
 
1.2.1 Leptin- interactions with neuropeptides, gut peptides and appetite regulatory 
effects 
Neuropeptides are peptides utilised by neurons for communication, they are 
essentially neuronal signalling molecules. Neuropeptides are also referred to as 
peptide hormones. Neuropeptides are involved in many brain functions including 
appetite, food intake and metabolism. The hypothalamus produces neuropeptides that 
stimulate and inhibit feeding. These peptides include, NPY, AGRP, POMC and CART 
amongst others. Peripheral signals, meaning signals coming from outside of the brain 
include CCK, PYY, leptin and ghrelin (Volkoff, 2006). Peptides acting as satiety 
signals primarily originate from the GI tract, but are also synthesized in the brain, 
which is why they are designated “gut-brain peptides” (Volkoff, 2006). Peripheral 
signals such as leptin can influence the brains release of appetite-related 
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neuropeptides and therefore also control food intake (Volkoff, 2006). Gut/brain 
peptides interact with specific receptors on major nerves or reach the brain directly 
via the bloodstream (Volkoff, 2006).  
 
Cholecystokinin (CCK) is secreted by the proximal intestine and is an anorexigenic 
GI peptide. The physiological role of CCK involves regulation of food intake, 
satiation and digestion; it has a key role in the regulation of the intestinal phase 
(Murashita et al., 2009; Webb et al., 2010). CCK stimulates the exocrine pancreas and 
discharge of bile from the gallbladder and also affects smooth muscle contraction in 
the jejunum and pyloric sphincter (Murashita et al., 2009). CCK-L and CCK-N in 
Atlantic salmon were described by Murashita et al., (2009) and were found to be 
highly expressed in the brain. Peptide YY (PYY) and NPY are peptide hormones 
belonging to the NPY family. NPY is mainly expressed in the hypothalamus and has 
strong orexigenic functions, while PYY is mainly expressed in the brain and anterior 
part of the intestine, including pyloric caeca and has anorexigenic functions. In 
mammals leptin activates the long form of leptin receptor LEPRB on central nervous 
system (CNS) neurons to mediate most leptin action. The LEPRB expressing neurons 
lie in regions associated with the regulation energy balance, such as the mediobasal 
hypothalamic (MBH) arcuate nucleus satiety centre (ARC) and lateral hypothalamic 
area (LHA) feeding centre. In mammals it seems that leptin action in the MBH is 
regulated through the LEPRB pro-opiomelanocortin POMC expressing neurons and 
their opposing LEPRB agouti-regulated protein (AGRP) neuropeptide Y (NPY) in the 
ARC (Leininger et al., 2009). These neurons are active in controlling satiety response 
and mediate the anorectic response to leptin, and also modulate energy expenditure 
and glucose homeostasis (Leininger et al., 2009). This is supported by Valen et al., 
(2011) who found that food intake and processing in Atlantic salmon causes a change 
in the mRNA expression of neuropeptides, NPY, cocain-amphetamine regulated 
transcript (CART) and PYY. CART, CCKL, POMCA1 and POMCB were found to 
increase within 3 hours of feeding while feed was in the stomach suggesting that these 
neuropeptides play a central anorexogenic role, similar to higher vertebrates (Valen et 
al., 2011). NPY and AGRP isoforms described as playing orexigenic roles in 
mammals were up regulated after feeding, which is opposite to the effect in mammals.  
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In mammals leptin reduces food intake through the hypothalamus orexigenic 
NPY/AGRP and anorexigenic POMC/CART neurons. Studies have indicated that 
similar mechanisms may to some extent also exist in salmon where leptin decreases 
hypothalamic NPY/AGRP mRNA and increases POMC/CART mRNA (Murashita et 
al., 2011). Atlantic salmon administered leptin through intraperitoneal (IP) osmotic 
pumps, showed increased expression of POMCA1 when compared to controls and 
also a significantly decreased growth rate (Murashita et al., 2011). Based on these 
results the authors suggested that leptin decreases food intake through the POMC 
pathway, which means that LEPA1 may have an anorexigenic role in the regulation of 
bodyweight in Atlantic salmon that compares with mammals. A direct effect of 
injected leptin on short-term feed intake still remains to be shown for Atlantic salmon. 
 
1.3 Ghrelin 
Ghrelin producing cells can be found in the oxyntic glands of the stomach in rats 
(Date et al., 2000) and colocalize with chromogranin A-immunoreactive cells, which 
suggests that ghrelin is produced by endocrine cells in the stomach (Date and 
Kangawa, 2012). Four types of cells have been identified in the oxyntic gland, the 
X/A cell is one of these and because there are similarities in the ultra structural 
features of ghrelin cells and X/A cells, ghrelin cells are believed to be a type of X/A 
cell (Date and Kangawa, 2012). Ghrelin was first described as an endogenous ligand 
for the growth hormone secretagogue receptor 1a or GHSR1A, the 28 amino acid long 
peptide with a unique fatty acid modification at the N-terminal third amino acid that 
comprises ghrelin was first discovered by Kojima et al., (1999). Ghrelin stimulates 
growth hormone (GH) release in vivo and in vitro, which supports that the hormone 
acts as an orexigen factor (Kaiya et al., 2008, Kaiya et al., 2013). Ghrelin is derived 
from pre-progrelin and undergoes a post-translational modification where a serine-3 
residue is covalently linked to octanoic acid. This post-translational acylation is 
unique to ghrelin and is necessary for the ghrelin to bind to the GHSR1A and cross the 
blood brain barrier (Karra and Batterham, 2010). In mammals ghrelin is the only 
gastrointestinal hormone known to increase feeding (Date and Kangawa, 2012) and 
has therefore been coined the “hunger hormone” in humans. In non-mammalian 
vertebrates the amino acid sequence of ghrelin has been reported in reptiles, birds, 
amphibians and fish including goldfish and rainbow trout (Kaiya et al., 2008) and 
Atlantic salmon (Hevrøy et al. 2011, Murashita et al. 2009). The ghrelin gene in 
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Goldfish, catfish, and seabream Sparidae spp. has four exons and three introns as in 
humans, the sequence identity of the short non coding 1st exon found in human and 
rodents ghrelin gene is not evident in the mentioned fish genes (Kaiya et al., 2008). 
However the ghrelin gene in rainbow trout is comprised of five exons and four introns 
as in humans, salmonids and rodents (Kaiya et al., 2008).  
 
Ghrelin producing cells have been found in the hypothalamic arcuate nucleus which is 
an appetite regulating centre in the brain (Kojima et al., 1999). Ghrelin cells have also 
been found in the duodenum, pancreatic A-cells, kidney and pituitary (Kaiya et al., 
2008). In teleosts ghrelin mRNA expression has mainly been found in the stomach or 
intestine, however ghrelin expression in other non-mammalian vertebrates has also 
been found in a variety of organs such as brain, hypothalamus, heart, pancreas, 
spleen, head kidney, trunk kidney, and gills of rainbow trout (Murashita et al. 2009, 
Kaiya et al., 2008). In tilapia Oreochromis niloticus ghrelin expression has been 
found in the brain, stomach, and gill and in the goldfish ghrelin expressions has been 
found in brain, hypothalamus, spleen, liver, head, gill and intestine (Kaiya et al., 
2008) 
 
The growth hormone secretagogue receptor (GHSR) which mediates the biological 
actions of growth hormone secretagogue (GHS) and ghrelin have been reported in 
teleosts such as rainbow trout, pufferfish and Atlantic salmon (Kaiya et al., 2008; 
Hevrøy et al., 2011). The GHS-R gene has two exons and one intron in seabream, 
pufferfish, tilapia, rainbow trout and Atlantic salmon. In rainbow trout the ghrelin 
receptor is called GHSR- like receptor, due to uncertainties in GHSRLR mRNA 
responses in a functional study in rainbow trout, and the same applies to Atlantic 
salmon because of the 99 % sequence similarities (Hevrøy et al. 2011). 
 
1.3.1 Ghrelin- interactions with neuropeptides and appetite regulatory effects 
Ghrelin is the only gastrointestinal hormone known to increase feeding (Date and 
Kangawa, 2012). In humans plasma ghrelin levels have been found to increase prior 
to meals and decrease after meals, indicating that ghrelin acts as a signal of 
expectations of meal (Shiiya et al., 2000). The fibres that contain ghrelin innervate 
neurons that produce NPY and AGRP, neuropeptides that are associated with 
increasing feeding (Zhou et al., 2013) and ghrelin administered to the brain activates 
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NPY and AGRP producing neurons in rats (Date and Kangawa, 2012). Ghrelin has 
also been shown as the only peripheral gut hormone to stimulate GH release in rats, 
indirectly through the vagal nerve afferent (Date et al., 2002) and directly through its 
action on the pituitary gland (Date et al., 2006). Ghrelin also stimulates GH release in 
fish, specifically in rainbow trout in vivo and in vitro (Kaiya et al., 2003) and hybrid 
striped bass Morone chrysops X saxatilis in vivo and in vitro (Picha et al., 2009). 
 
Ghrelin has orexigenic effects in mammals and promotes feed intake, weight gain and 
adiposity. In higher vertebrates such as humans intravenous infusions of ghrelin cause 
an increase in feed intake (Wren et al., 2001), and in rats Rattus spp. ghrelin 
intracerebroventricular (ICV) injections increase food intake and body weight (Locke 
et al., 1995), also with orexigenic properties that are independent of GH releasing 
properties (Torsello et al., 1998). In goldfish, Matsuda et al., (2006) found that ICV 
and IP administration of ghrelin stimulated food intake and suggest circulating ghrelin 
derived from peripheral tissues acts via primary sensory afferent pathways on feeding 
centres in the brain. This is further supported by Murashita et al., (2009) who found 
that a six day starvation period led to increased expression of GHRL1 in the GI tract, 
suggesting an orexigenic role of ghrelin in Atlantic salmon. However the picture is 
not complete concerning the role of ghrelin in salmonids. In rainbow trout ghrelin 
injections and implants have been found to reduce food intake (Jönsson et al., 2007; 
Kling et al., 2012), while circulating plasma ghrelin levels seem to peak after short 
time starvation (Pankhurst et al., 2008). In Atlantic salmon circulating ghrelin 
concentrations are higher after two days of food deprivation but no ghrelin peaks were 
shown after fourteen days of starvation (Hevrøy et al., 2011). Hevrøy et al., (2011) 
also found a down-regulation of stomach ghrelin1 mRNA in food deprived fish after 
two days but no effect after fourteen days and no effects on GHSR1aLR mRNA 
expression, however in a study on salmon kept at elevated temperatures fish 
developed low feed intake at nineteen degrees which was associated with a lower 
ghrelin plasma concentration and down-regulation of stomach GHRL1 and 
hypothalamic GHSR1aLR mRNA expression (Hevrøy et al., 2012). Murashita et al., 
(2009) found a significant up-regulation of stomach ghrelin-1 mRNA after six days of 
food deprivation. The results of increased plasma ghrelin concentrations and stomach 
ghrelin mRNA responses may suggest that ghrelin is a short time energy regulator 
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during starvation in Atlantic salmon and ghrelin suppression may be related to energy 
homeostasis (Hevrøy et al., 2012) 
 
1.4 Plasma metabolites as an indicator of metabolic status 
Plasma metabolites such as glucose, lactate, free fatty acids (FFA), triglycerides and 
D-3-Hydroxybutyrate are indicators of metabolic status and energy balance in 
teleosts. Glucose functions as a source of energy and is usually available through the 
diet. However when fish go through periods of starvation or intense activity such as 
burst swimming available glucose reserves may become depleted and further 
synthesis of glucose is maintained through gluconeogenesis. This is the process of 
synthesizing glucose from non-carbohydrate sources such as lactate or glucogenic 
amino acids (Morata et al., 1982). When glucose is in limited supply evidence from 
teleosts suggest the organs of several fish use β-hydroxybutyrate and acetoacetate as 
fuels. β-hydroxybutyrate utilization has been measured in rainbow trout brain and 
occurs at 1% the rate of glucose and lactate metabolism, which is a contrast to 
mammals where oxidation rates of ketone bodies are comparable to those of glucose 
and lactate (Soengas and Aldegunde, 2002). The lypolitically-generated FFA are 
important sources of energy for cells and are substrates for lipid biosynthesis (Chung 
et al., 1998). Fatty acids also play a significant role in glucose homoeostasis and 
triglycerides specifically enable the transfer of adipose fat and blood glucose from the 
liver (Menoyo et al., 2006). Changes in the levels of triglycerides in plasma indicate a 
change in glucose metabolism, thus measuring triglyceride levels in blood can give an 
indication of metabolic status in vertebrates such as fish. Plasma free fatty acids are 
considered to be the most dynamic form of lipid transport from the lipid depots to the 
various utilising tissues. In fish, red muscle fibres are known to possess a high 
capacity for FFA catabolism. In contrast to mammals, which possess a specialised 
adipose tissue, the lipid reserves of fish may be located in several tissues including 
mesenteric fat, liver and red muscle (Van Rajj, 1994). Compared with higher 
vertebrates in which plasma FFA levels usually range between 0.4 and 0.6 µmol/ml, 
plasma levels of fish are much more variable. Levels ranging from 0.09 to 2.84 
µmol/ml have been reported. In fish most reports are that plasma levels range between 
0.3 and 1.0 µmol/ml. The replacement time of plasma FFA is within minutes and fatty 
acid metabolism is of major importance for the energy metabolism in fish, thus the 
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level and fatty acid composition of plasma FFA form a very dynamic reflection of 
lipid metabolism (Van Rajj, 1994). In fatty fish such as salmonids starvation 
stimulates lipid metabolism and white muscle protein catabolism (Echevarria et al., 
1997), so high levels of FFA and triglycerides in the plasma could indicate lack of 
feeding. When oxidation of carbohydrates and lipids are unbalanced acetoacetate and 
β-hydroxybutyrate serve as transportable units of fat for oxidation in peripheral 
tissues (Willmott et al., 2005). Some metabolites also function as an indicator of 
stress, as glucose and lactate form part of the secondary stress response in salmonids 
(Iversen et al., 2005). It is important to consider indicators of stress as changes in the 
levels of metabolites may not necessarily be due to experimental parameters and 
stress could produce confounding results, especially when examining metabolic 
functions. 
 
1.5 An individual-based system as a method of studying peptide hormone effects 
in Atlantic salmon 
Atlantic salmon are an important aquaculture species in Norway and globally, and 
serve as a model species for the potential cultivation of other teleosts. Leptin and 
ghrelin are peptide hormones with key regulatory effects on feed intake and energy 
homeostasis in salmonids (Murashita et al., 2008; Kaiya et al., 2008).Whether 
administration of leptin or ghrelin will affect feed intake in Atlantic salmon, remains 
unknown.  
 
There are different routes of delivery when administrating peptide hormones, which 
are known to cause different methodological challenges. The methodological 
challenges may  in turn yield varying physiological  results. Hormones such as leptin 
and ghrelin can be administered ICV or IP, as hormone and gut-brain peptide 
injection studies have yielded results in mammals such as rats Rattus spp. (Rüter  et 
al., 2003). In non mammalian vertebrates ICV and IP studies have also been 
conducted on Nile Tilapia Oreochromis niloticus, hybrid striped bass, grass carp 
Ctenopharyngodon idella, Atlantic salmon, coho salmon Oncorhynchus kisutch  with 
varying effects on appetite regulating systems (Shved et al., 2011; Picha et al., 2009; 
Zhou et al., 2013; Einarsson et al., 1997; Baker et al., 2000). Baker et al., (2000) 
found that recombinant human leptin administered to coho salmon did not affect 
growth or food intake, energy stores, gonad weight, pituitary content of FSH or 
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plasma levels of IGF1, GH or thyroxine. Therefore Murashita et al., (2011) suggested 
that in order to obtain accurate results for leptin, species-specific peptides must be 
applied. The protocol for the production of recombinant leptin was established by 
Murashita et al., (2008) in rainbow trout, since then the technique has also been 
utilised for Atlantic salmon (Murashita et al., 2011). The cDNA sequence of Atlantic 
salmon LEPA1 was utilised in order to produce recombinant Atlantic salmon LEPA1 
in Escherichia coli (Murashita et al., 2011). This method was also applied for the 
current study.  
 
Ghrelin has been purified and characterized in a number of fish including, japanese 
eel Anguilla japonica, channel catfish Ictalarus punctatus and rainbow trout (Miura et 
al., 2009). The protocol for purifying ghrelin from the stomach of rainbow trout was 
established by Kaiya et al., (2003) and was utilized for the production of ghrelin for 
this study. Two types of ghrelin have been found in rainbow trout, rtGHRL and des-
VRQ-rtGHRL Kaiya et al., (2003) and according to Murashita et al., (2009) the 
GHRL1 and GHRL2 found in Atlantic salmon were similar to those in rainbow trout 
and the deduced mature peptide sequences were identical in both species. Due to the 
similarity of ghrelin found in rainbow trout and Atlantic salmon, purified rainbow 
trout ghrelin most likely have similar effects when injected IP in Atlantic salmon.  
 
A good experimental setting for testing any effect on appetite must also permit 
accurate registrations of feed intake. A method for measuring the feed uptake of 
individual salmonids is virtually non-existent, because it is extremely difficult to get 
Atlantic salmon to feed individually in tanks. Fish are increasingly used in a range of 
laboratory experiments yet there is little data and information on how fish should be 
housed. Housing conditions can influence the behaviour and physiology of laboratory 
animal, thus enriching empty environments by providing structural complexity or the 
companionship of other individuals is considered beneficial as it could decrease 
abnormal behaviour. It is important to evaluate the housing environment as it may 
influence the validity of experimental data, especially if housing with an unsuitable 
environment produces abnormal behaviour (Brydges and Braithwaite, 2009). Roberts 
et al., (2011) showed that changes in rearing conditions had rapid and marked effects 
on risk-taking behaviour in Atlantic salmon, which indicates it is possible to modify 
at least one component of behaviour known to have clear adaptive implications 
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through environmental enrichment. An individual based method was developed in 
association with the aquaculture research station at Matre, in a pilot study with IP 
injected leptin. In the wild, parr show marked territoriality, occupy fixed positions 
faced into current flows and can be highly aggressive. When the salmon smoltify 
these behaviours change and the fish display schooling behaviour with downstream 
orientation and also swim with the current. This behaviour can be observed in tanks 
on farms during smoltification, at the same time appetite is stimulated and fish begin 
to feed more intensively (Stead and Laird, 2002). Prior to being placed in tanks 
individually, three juvenile Atlantic salmon were kept together encouraging schooling 
and feeding behaviour. After feeding behaviour was attained one individual juvenile 
Atlantic salmon was placed in each tank and hand fed, allowing each fed pellet to be 
counted and excess uneaten feed to be collected.  
 
Netting and handling in connection with experimentation for weighing and injections 
may impose severe stress to fish. Salmon is known to be particularly sensitive to such 
stress and it is well known that they may cease to eat for a long period after 
experimental handling. In the current experiment we used a sedation protocol 
including both AQUI-s and MS-222 that allowed for the careful removal of each fish 
from the tank causing minimum stress so as not to interfere with feeding. The fish 
could be removed, injected with a recombinant peptide hormone, in this case leptin or 
ghrelin, thereafter replaced in the tank for recovery. Thus feed intake prior to and 
after treatment was accurately recorded and measured for each individual fish, with 
minimum interference. The recent development of such a model for Atlantic salmon 
(Hevrøy et al., unpublished) is of great importance in order to accurately measure the 
hormone effects on feed intake and was used in the current work. 
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1.6 Aims and objectives 
The main aim of this project was to examine the effects of administered leptin and 
ghrelin on appetite, feed intake and neuropeptides in Atlantic salmon. The research 
will help provide a better understanding of the mechanisms that regulate appetite and 
feed intake in salmonids. 
 
Main objective 
• Assess the appetite effect of recombinant hormones LEPA1 and rainbow trout 
GHRL1A in Atlantic salmon in an individual based system, in order to better 
understand appetite regulation and feed intake in salmon. 
Minor objectives 
• Investigate the effects of recombinant leptin and ghrelin on feed intake in 
salmon 
• Examine the underlying effects of observed changes in feed intake focusing on 
the neuropeptides involved in appetite regulation in the brain  
• Identify to what extent energy metabolism is influenced by leptin and ghrelin 
in selected tissues and organs including liver, stomach and brain. 
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2. Materials and Methods 
 
In order to examine the function of leptin and ghrelin in Atlantic salmon individual 
injection experiments were performed in order to evaluate feed intake response.  The 
performance response was confirmed through the collection of organ and plasma 
samples The individual feed intake model (Figure 1) utilized for this experiment was 
developed in collaboration with Matre Aquaculture Research Station. 
Figure 1 Overview of experimental setup (Hevrøy, unpublished) 
 
Atlantic salmon were selected from stock and distributed throughout experimental 
tanks, three fish in each tank. After an acclimation period, during which most of the 
fish established a regular feed intake, individual fish were sampled during which 
weight and length was measured. One individual from each tank was selected for the 
next phase of the experiment. The selected fish had displayed feeding behaviour 
during the acclimation period and was within the mean size range of the group. The 
fish were fed individually and once the feeding had stabilized, the fish were sedated 
and anesthetized, weighed and measured before they were injected with hormone (IP) 
and returned to the tank. Feeding resumed rapidly and the fish were monitored for a 
further three to four days before they were removed and killed for final sampling.  
 
2.1 Fish and experimental conditions 
Two experiments were conducted. Both experiments were conducted at the IMR - 
Matre Aquaculture Research Station, Matre, Norway (60,87º N 5,58º E). The first 
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experiment was conducted during December 2011, and the second during January 
2012.  
 
2.1.1 Experiment one  
On the 1st of December 2011, 48 post smolts (NLA strain, 0+) with an approximate 
body weight of 90-100g where randomly distributed in 16, 0.5 x 0.5 x 0.4 m indoor 
tanks with 85 L flow-through water volume, so that each tank contained three 
individuals.  The water temperature was held constant at 12 °C and oxygen was added 
in order to keep the saturation above 90 %. Artificial light with natural day length was 
applied. The fish were kept on a 20/4 light regime prior to competition period. During 
the first 4 days of acclimation the light was kept on a 12/12 regime, however this 
interfered with the first feeding at 09:00 so the light regime was changed to 16/8. The 
light regime remained the same throughout the first and second experimental period.  
 
The fish were handfed four times a day at 09:00, 12:00, 15:00 and 18:00. After 8 days 
all the individual fish had established a regular and high daily feed intake and 
consumed between 100 and 130 pellets per tank per day. Prior to removal of fish, 
pellets were hand fed into each tank and feeding behaviour was observed. Fish from 
tanks in which all three fish showed competitive feeding behaviour where selected for 
further experimentation. To prevent stress the fish were sedated in the tanks prior to 
netting as follows: Water flow was stopped and 1/3 of water was drained from the 
tank. 4 ml of AQUI-S (12 mg L-1) (AQUI-S, New Zealand) dissolved in warm water 
was administered into each tank permitting all individuals to be sedated while they 
were in the tank. This normally took 3 to 5 min. After the fish had been removed from 
the tank, waterflow was returned to the original level to wash out remnants of 
sedating compound and volume to return to normal levels. After netting, the fish were 
anaesthetized with (FINQUEL) MS 222 (50 mg L-1) before weight (OHAUS – 
Sterner Fishtech, Norway) and fork lengths were registered. Fish weighing more than 
150 grams and less than 100 grams were discarded. The mean weight at the start of 
the experimental period was 130g±12.8g. One feeding individual was selected and 
returned to the tank. This procedure was repeated with all tanks, untill each of the 16 
tanks contained one fish. 
 
  26 
The experimental period started on the 8th of December and fish were handfed for 
another 7 days until the 14th of December at which point feeding had stabilized. At 
that point all fish were being fed 160 pellets a day (the uneaten pellets were removed 
and counted before the next meal) and the mean consumed pellets was 60.5±28.4. 
Fish were being fed until satiety. The fish were sedated and collected according to the 
method described previously, then they were injected with leptin, ghrelin or a sham 
injection for the control group. The fish were injected using a random design.  The 
fish were handfed for another 3 days then netted, and quickly killed with a blow to the 
head on the 4th day (19th of December) 4 h post feeding. Blood was carefully 
withdrawn using a syringe. Aliquots of blood where stored in eppendorf tubes that 
were kept in ice before centrifugation and plasma was prepared for further analysis. 
Samples of brain, liver and stomach were rapidly but carefully removed, collected and 
flash-frozen in liquid nitrogen stored at -80º and then transferred to a -80º freezer 
where they were kept until they were analyzed.  
 
2.1.2 Experiment two 
For Experiment two the start of the acclimation period was monitored by personnel at 
IMR - Matre Aquaculture Research Station. The average size and weight of fish 
entering the acclimation period was not registered. The feed consumption during the 
acclimation period was not registered. Weight and length measurements were 
recorded for each of the 3 individuals from the selected tank, fish weighing more than 
210 grams and less than 150 grams were discarded. The mean at the start of the 
experimental period was 191.5g±16.4g. The experimental period was started on the 
13th of January and fish were handfed for 13 days (26th January) until feeding had 
stabilized. At that point fish were being fed 190 pellets a day and the mean pellet 
consumption was 70.9±32.2. The fish were sedated, netted, injected and replaced 
according to the method described previously. Fish were handfed for 4 days post 
injection then netted, and quickly killed with a blow to the head on the 5th day (31st 
January) 4 h post feeding .  
 
2.2 Feeding 
The salmon where fed in excess four times a day at 09:00, 11:00, 13:00 and 15:00 
using hand feeding and waste feed collectors. All fish were fed a commercial standard 
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diet, Nutra Parr LB 3 3.0 5mg 3.0mm (Skretting, Norway) with a mean dry weight of 
0.0196 g. 
 
2.3 Preparation for administration of leptin and ghrelin.  
Recombinant leptin was prepared according to the published protocol (Murashita et 
al., 2011) Crisco All Vegetable Shortening (solid at room temperature) was heated to 
50C in a water bath and mixed 50:50 with Vegetable oil and temperature adjusted to 
37C. Then, the appropriate amount of rsLEPA1 was weighed and dissolved in 0.5 ml 
NaOH (0.01N) and HCl (0.1N) solution. The dissolved hormone was transferred to 
the shortening solutions to achieve doses of 1 and 5µg rsLEPA1/rtGHRL per gram 
body weight. Solutions were made in order to be able to inject 5µl per gram body 
weight. The protocol for preparing hormone in vegetable oil was also followed for 
rtGHRL. 
 
2.4 Administration of leptin and ghrelin 
The recombinant Atlantic salmon specific leptin dosage was set by a pilot trial (July 
2011 – Data not shown). Based on previous experiments it was presumed there would 
be dose-dependent effects on feed intake as for ex. recombinant LEP injected ICV in 
chickens produced a dose-dependent reduction in feed intake, with the highest dose  
(10µg total injected recombinant human leptin per chicken) producing the most 
prominent reduction in feed intake (Denbow et al., 2000). Individuals in treatment 
groups were given a specific dose, however in the present study there did not appear 
to be any clear dose-response relationship or trend (data not shown) so results are 
analysed and presented as the mean of a treatment.  
 
2.4.1 Experiment one 
Leptin (rsLEPA1; 150 amino acids; 16780 Da) and ghrelin (purified rainbow trout 
GHRL, 23 amino acids; 2082 Da) was administered at equal molar levels: 0.08, 0.16, 
0.24, 0.32 and 0.40 nmol/g fish. This gave dosages of 1.34, 2.68, 4.03, 5.37 and 6.71 
µg/g fish with leptin and 0.17, 0.33, 0.50, 0.67 and 0.83 µg/g fish with ghrelin.  
 
2.4.2 Experiment two 
Leptin doses were set and administered at the following molar levels: 0.02, 0.04, 0.16, 
0.24, 0.32 and 0.40 nmol/g fish. This gave dosages of 0.34, 0.67, 2.68, 4.03, 5.37 and 
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6.71 µg/g fish. Ghrelin doses were set and administered at the following equal molar 
levels: 0.06, 0.13, 0.19, 0.26 and 0.32 nmol/g fish. This gave dosages of 0.17, 0.33, 
0.50, 0.67 and 0.83 µg/g fish.  
 
2.5 Sampling and anesthesia  
All fish were sedated using ISO-eugenol (in tank) and anaesthetized with MS 222 
before weight and length registration and sampling of tissue and organs. Fish that 
were used for blood and RNA samples were not anesthetized, but killed with a blow 
to the head. 
 
2.6 Feed uptake and growth  
Feed intake was recorded daily in a MS Excel spreadsheet (Appendix 1). 
• Specific growth rate (SGR)  
• Feed uptake, feed factor (feed efficiency), FCR feed conversion rate 
 
2.7 Sampling: Energy partitioning and physiology 
• Samples for gene expression analyses in whole brain, liver and stomach   
• Blood plasma: nutrient metabolites (FFA, triglycerides, glucose, lactate and 
D-3-Hydroxybutyrate) and hormone (ghrelin) 
Tissues for sampling of RNA (Liver, brain, stomach) were kept on liquid nitrogen 
before storage at – 80 °C. 
 
2.8 Gene expression analysis: qPCR 
Expression analysis for the selected genes was conducted as described below. Sample 
preparation (starting from RNA extraction) of the brain tissue was performed at the 
MDB laboratories at BIO, Bergen, Norway; sample preparation and analysis of liver 
and stomach was performed at the molecular lab at NIFES, Bergen, Norway. 
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2.8.1 Brain samples 
RNA extraction from collected brain samples was performed using the Tri-Reagent 
protocol according to manufacturer’s recommendations. Tri-Reagent (Sigma Aldrich, 
St luis, USA) is an improved version of the single-step total RNA isolation reagent 
developed by (Chomczynski and Sacchi, 1987). Homogenisation was done using a 
Fast Prep machine (Savant Instruments, Holbrook, NY, USA). The remaining pellet 
was reconstituted in nuclease free H20, heated for 55-60ºC for 10-15 minutes and then 
the optical density (OD)value was assessed using the Nanodrop® ND-1000 UV-Vis 
Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). Samples had a 
concentration between 400 and 1000 ng/µl with A260/A280 values between 1.9 and 2.1. 
For A260/A230 a value of 2.3 for was considered optimal. For storage samples were 
precipitated with 3M NaAC pH 5.5 a 1/10 of sample volume and EtOH at 2.5 times 
the total volume of the sample. DNA removal was performed using an optimized 
protocol for the Turbo DNA-free kit (Life technologies, Carlsbad, California, USA). 
RNA integrity was assessed using the 6000 Nano Labchip kit on the Agilent 2100 
Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). All samples had RIN 
values above 8.80. cDNA synthesis was performed using the Invitrogen Superscript 
III Reverse transcriptase kit (Invitrogen Life Technologies, California, USA) 
according to the manufacturer’s instructions. A minus reverse transcriptase (minus 
RT) control was created. The cDNA was incubated using the following reaction 
protocol, 60 minutes at 50ºC, 15 minutes at 70ºC. 
 
Duplicates of each sample were run in 25 µl reactions, consisting of 1X Power SYBR 
Green Master Mix (Life technologies, UK), 400 nM primers and water. Sample and 
dilution curve dilutions are given in Table 1.  For ghrelin like receptor assays in brain 
we used 200 nM of primers. A negative control of pooled RNA from all samples and 
no reverse transcriptase was included. A negative template control (NTC) was 
included on all plates. No signal was observed in the negative controls. A between 
plate control (BPC) was used on all plates existing of pooled cDNA from all samples 
from both experiments. 5 step dilution curves were constructed, and consisted of 
pooled cDNA from all samples from both experiments. 
 
PCR parameters for all assays, except POMC-B were as follows; a first denaturation  
at 95 °C for 5 min then 45 cycles at 95 °C for 30 s, 60 °C for 30 s and 72 °C for 30 s. 
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POMC-B had an annealing temperature of 62 °C. A melting curve was performed for 
each assay, in order to verify the absence of primer dimers (60–95 °C read every 
0.5 °C and held for 0,5 s). The melting curve analysis showed a single peak for each 
assay, confirming PCR specificity (data not shown). 
 
Table 1 Criteria set for the construction of dilution curves, and sample dilution factors   
Gene 
Input 
RNA in 
to cDNA 
synthesis 
(ug) 
dilution 
curve, initial 
dilution 
dilution factor 
in dilution 
curve 
sample 
dilution 
POMCA1 4  1:4 10  1:5 
POMCA2 4  1:4 10  1:5 
AGRP1 4  1:4 10  1:5 
NPY 4  1:10 2  1:20 
CART 4  1:10 2  1:20 
LEPR1 2  1:5 2  1:10 
LEPR2 2  1:5 2  1:10 
β-ACTIN 4  1:100 2  1:400 
RPL13 4  1:100 2  1:400 
EF1AB 4  1:100 2  1:400 
POMCB 4  1:4 10  1:5 
POMCA2S 4  1:4 10  1:5 
AGRP2 4  1:4 10  1:5 
CCKL 4  1:10 2  1:20 
CCKN 4  1:10 2  1:20 
PYY 4  1:5 2  1:10 
GHSR1A-LR 4  1:10 2  1:20 
 
2.8.2 Liver and stomach  
RNA was extracted from samples using a Qiazol reagent and DNA removal was 
performed using the EZ1 cleaning robot. 750µl quiazol was added to precellys tubes 
containing 3-4 beads. For liver 50µg of tissue were added to tubes and for stomach 
100µg tissue were added to the tubes. The samples were homogenized using the 
precellys. The blank supernatant was transferred to 2ml sample tubes for the EZ1 
robot. DNase was added to tubes for the EZ1 robot. Elution tubes were also added to 
the EZ1 robot. Dnase removal program was run for 45 minutes on the EZ1 robot.  
 
Prior to synthesizing cDNA sample RNA integrity was assessed using the Agilent 
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA) RNA Nano assay. 
  31 
Only samples with RIN values above 7 were utilized for further analysis. All samples 
had RIN values above 7.  
 
cDNA synthesis was performed using the Roche reverse transcriptase  AMV kit 
according to the manufacturer’s instructions (Roche Applied Science, Bavaria, 
Germany). Stomach and liver samples from each fish were run in duplicates or 
triplicates (250 ng) on 96 well plates for Reverse transcription. A minus reverse 
transcription control (–RT) was created. A No template control (NTC) and No 
amplification control (NAC) were also created. The PCR plate was placed in the PCR 
machine and the RT reaction was run at 50°C for 50 minutes. qPCR amplification and 
analysis was performed on a LightCycler 480 Real-time PCR system (Roche Applied 
Science, Bavaria, Germany). The LightCycler 480 SYBR Green master mix kit 
(Roche Applied Science, Bavaria, Germany) was utilized according to the 
manufacturer’s instructions, the mastermix contained gene specific primers at a final 
concentration of 500 nM. Two µl of cDNA from each well were transferred to a 
realtime plate and ten µl of realtime master mix was added by a pippetting robot. The 
qPCR protocol in Table 2 was employed. Efficiency of qPCR was monitored using 2-
fold dilution curves comprised of a pool of all RNA using a five point dilution range, 
500ng – 31.25 ng/µl. PCR parameters for all assays were as follows; a first 
denaturation at 95 °C for 5 min, then 45 cycles at 95 °C for 10 s, 60 °C for 10 s and 
72 °C for 10 s.  
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2.9 Primers  
PCR primers for target genes insulin-like growth factor 1 (IGF1), insulin-like growth 
factor 2 (IGF2), growth hormone receptor 1 (GHR1), growth hormone receptor 2 
(GHR2) were designed at NIFES with the Primer Express software and Biosoft 
software as previously described by Hevrøy et al., (2008). Ghrelin1 (GHRL1A) and 
ghrelin2 (GHRL1B) were designed with the Primer Express software based on 
sequences of Atlantic salmon as described by Hevrøy et al., (2011). Leptin A1 
(LEPA1), leptin A2 (LEPA2), leptin receptor 1 (LEPR1), leptin receptor 2 (LEPR2) 
were designed and described at the MDB lab by Rønnestad et al., (2010). 
Proopiomelanocortin a1 (POMCA1), proopiomelanocortin a2 (POMCA2), 
proopiomelanocortin a2s (POMCA2S), proopiomelanocortin b (POMCB), agouti-
related peptide 1 (AGRP1), agouti-related peptide 2 (AGRP2), cocaine and 
amphetamine related transcript (CART), neuropeptide Y (NPY), peptide YY (PYY), 
cholecystokinin (CCKL and CCKN) as described previously by Murashita et al., 
2009a; 2009b.; 2011). Ribosomal protein L13 (RPL-13), beta actin (β-actin) and 
elongation factor 1 alpha beta (EF1-αb) were used as reference genes as described 
previously by Hevrøy et al., (2011).  
 
Table 2 Primer sequences of reference and target genes used for RT-PCR mRNA expression in brain, 
stomach and liver of Atlantic salmon. Reference genes; ribosomal protein L13 (RPL-13), beta actin (β-
ACTIN), elongation factor 1 alpha beta (EF1-αb). Target genes; leptin A1 (LEPA1), leptin A2 
(LEPA2), leptin receptor 1 (LEPR1), leptin receptor 2 (LEPR2), growth hormone receptor 1 (GHR1), 
growth hormone receptor 2 (GHR2), insulin-like growth factor 1 (IGF1), insulin-like growth factor 2 
(IGF2), ghrelin1a (GHRL1A), ghrelin1b (GHRL1B), proopopmelanocortin a1 (POMCA1), 
proopopmelanocortin a2 (POMCA2), proopopmelanocortin a2s (POMCA2S), agouti-related peptide 1 
(AGRP1), agouti-related peptide 2 (AGRP2), cocaine and amphetamine related transcript (CART), 
neuropeptide Y (NPY), cholecystokinin-L (CCK-L).  
Target Sequence of primers 
Primer 
efficiency 
RPL-13 Forward 5′-CCAATGTACAGCGCCTGAAA 96% 
 Reverse 5′-CGTGGCCATCTTGAGTTCCT  
β-ACTIN Forward 5′-CCAAAGCCAACAGGGAGAA 94% 
 Reverse 5′-AGGGACAACACTGCCTGGAT  
EF1AB Forward 5′-TGCCCCTCCAGGATGTCTAC 101% 
 Reverse 5′-CACGGCCCACAGGTACTG  
LEPA1 Forward 5′-TTGCTCAAACCATGGTGATTAGGA 91% 
 Reverse 5′-GTCCATGCCCTCGATTAGGTTA  
LEPA2 Forward 5′-TGGGAATCAAAAAGCTCCCTTCCTCTT 106% 
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 Reverse 5′-GCCTCCTATAGGCTGGTCTCCTGCA  
LEPR1 Forward 5′-TAGAGGTAATTGAGGAGAAGGACCTCT 99% brain 
 Reverse 5′-AACATAGAGTCCTGACTCCCGAGCAA 109% liver 
LEPR2 Forward 5′-GGAGGAGAAGGACCTGGATTACCT 83% 
 Reverse 5′-AACATAGAGTCCCGACACCCAAGTAG 104% liver 
GHR1 Forward 5′-TGGACACCCAGTGCTTGATG 111% 
 Reverse 5′-TCCCTGAAGCCAATGGTGAT  
GHR2c Forward 5′- 106% 
 Reverse 5′-  
IGF1 Forward 5′-TGACTTCGGCGGCAACA 186% 
 Reverse 5′-GCCATAGCCCGTTGGTTTACT  
IGF2 Forward 5′-TGCCAAACCTGCCAAGTCA 96% 
 Reverse 5′-GGCACCATGGGAATGATCTG  
GHRL1A Forward 5′- CCCTCCCAGAAACCACAGGTA 84% 
 Reverse 5′- TATTGTGTTTGTCTTCCTGGTGAAG  
GHRL1B Forward 5′- TCCCAGAAACCACAGGGTAAA 85% 
 Reverse 5′- GAGCCTTGATTGTATTGTGTTTGTCT  
POMCA1 Forward 5′-TGGAAGGGGGAGAGGGAGAG 114% 
 Reverse 5′-CGTCCCAGCTCTTCATGAAC  
POMCA2 Forward 5′-CTGGAGGCTGGGACTGCGGA 94% 
 Reverse 5′-CGTCCCAGCTCTTCATGAAC  
POMCA2S Forward 5′-AGACGAGAGCTGGGGGGAGT 190% 
 Reverse 5′-CGTCCCAGCTCTTCATGAAC  
POMCB Forward 5′- GACTAAGGTAGTCCCCAGAACCCTCAC 84% 
 Reverse 5′-GACAGCGGTTGGGCTACCCCAGCGG  
AGRP1 Forward 5′-GCGTTCTCCCCGTCGCTGTA 107% 
 Reverse 5′-TGTTAGGGGCGCCTGTGAGC  
AGRP2 Forward 5′-GCGGTGTGGTCGTCTGATGG 95% 
 Reverse 5′-GGGCCCAGTCTCCAGCAGTG  
CART Forward 5′-AGCAACTGCTTGGAGCACTACATGAC 98% 
 Reverse 5′-CAGTCGCACATTTTGCCGATTCTCGCGCCC  
NPY Forward 5′-ACTGGCCAAGTATTACTCCGCTCTCA 89% 
 Reverse 5′-CTGTGGGAGCGTGTCTGTGCTCTCCTTCAG  
PYY Forward 5′-AGACCAGCGATTTGCTGCAAAGACACCAGT 96% 
 Reverse 5′-AGACCAGCGATTTGCTGCAAAGACACC  
CCK-L Forward 5′-CAGCCACAAGATAAAGGACAGAGA 86% 
 Reverse 5′-GGTCCGTATGTTTCTATGAGGAGTACG 
 
 
CCK-N Forward 5′- AGAAGTCCCTTCATCCCTCTCTCAAACACT 85% 
 Reverse 5′- AGAAGTCCCTTCATCCCTCTCTCAAACACT  
GHRLR Forward 5′-GCACACAGGGACAAGAGCAA 83% 
 Reverse 5′-CCTCGGAGGAATGGGACATA  
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2.10 Plasma Ghrelin 
Ghrelin in plasma was measured with a heterologous assay using a 125I-
radioimmunoassay kit for human ghrelin (Linco Research Inc., St. Charles, Missouri) 
which is specfic for biologically active (octanoylated) ghrelin. The assay has been 
validated for use in Atlantic salmon (Pankhurst et al., 2008; Hevrøy et al., 2011) 
 
2.11 Plasma metabolites  
Triglycerides and glucose in plasma were measured with the MAXMAT 
immunoassay kit for human triglycerides and glucose (MAXMAT S.A. Zac du 
Millenaire 290, rue Alfred Nobel, 34000 Montpellier, France). FFA in plasma was 
measured with the DIALAB immunoassay kit for FFA (DIALAB, A-2351 Wiener 
Neudorf, Austria). Lactate in plasma was measured with the SPINREACT 
immunoassay kit for human lactate (SPINREACT , S.A.U, Ctra. Santa Coloma, 7 E-
17176 Sant esteve de bas (GI), Spain). D-3-Hydroxybutyrate was measured with the 
RANDOX immunoassay kit for D-3-Hydroxybutyrate (Randox laboratories limited, 
55 Diamond road, Crumlin, County Antrim, BT29 4QY, United Kingdom).  
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2.12 Calculations  
2.12.1 TGC ratio 
The somatic growth of the fish was measured as the thermal growth coefficient ratio: 
 
w2 =    final weight  
w1 =    initial weight 
∑T =    sum of daydegrees 
 
ratio =  
 
postinjectionTGC =  the thermal growth coefficient prior to injection 
preinjectionTGC =  the thermal growth coefficient post injection 
 
2.12.2 Daily feed intake  
Feed intake was measured as DFI % of BW with the following formula.  
 
 
fu = feed uptake 
iw = initial weight 
fcr = feed conversion ratio 
 
can also be calculated as: 
 
 
 
pf = pellets fed 
pc = pellets collected 
paw = pellet average weight 
iw = initial weight of fish 
fi = feed intake 
g = growth 
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2.13 Statistical analysis 
Statistical analysis was carried with the use of the software IBM SPSS statistics 19 
(IBM corporation, New York, USA), graphs and tables where generated in Microsoft 
Excel 2003 (Microsoft, Redmond, Washington, USA). Each treatment group, leptin, 
ghrelin and a control, represents an independent statistical unit. In Experiment one, 
control n=6, leptin n=3, ghrelin n=5. In Experiment two, control n=4, leptin n=6, 
ghrelin n=5. A 95% confidence level was chosen for all tests, p<0.05 for statistical 
significance. All data was tested for a normal distribution, because parametric tests 
for a difference depend on a normally distributed dataset. In order to visually examine 
the distribution of the data a frequency distribution was created in SPSS, to determine 
whether the frequency distribution departed from normality the Shapiro-wilk was 
used. If the distribution did not differ significantly from a normal distribution 
(p<0.05), then the data set was considered normal and a general parametric one-way 
ANOVA was utilised to test for a difference between a treatment group and the 
control. If the data set differed significantly from a normal distribution (p>0.05), then 
the data set was considered not to conform to a normal distribution and the Mann-
Witney U test (a general non-parametric test for two groups) was utilised to test for a 
difference between a treatment group and the control.  
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3. Results  
 
3.1 Feed intake 
Daily feed intake (DFI) expressed as % of bodyweight (BW) gradually increased and 
stabilized in leptin, ghrelin and control groups in experiments one and two (Figure 2). 
When feed intake stabilized at day 8 all fish where injected IP. Injection of leptin 
appears to lead to reduced feed intake in both experiments. However, a significant 
decrease in feed intake was only observed in the leptin group in Experiment two 
(Figure 2C; p=0.001 ANOVA). In Experiment two there was no significant difference 
in feed intake in the sham injected control group (Figure 2C: p=0.193 one way 
ANOVA). No significant difference in feed intake was found post injection in the 
leptin or ghrelin treated groups in Experiment one or in the ghrelin treated group in 
Experiment two (Figure 2A, B, D; p>0.05 ANOVA) 
 
 
Figure 2 Daily feed intake of Atlantic salmon in % of bodyweight. Experiment one, leptin treated n=3, 
ghrelin treated n=5, sham treated control n=6. Experiment two, leptin treated n=6, sham treated control 
n=4. D Experiment two, ghrelin treated n=5, sham treated control n=4. Mean ± SE represented by bars, 
the mean is represented by DFI%BW each day of each fish in a treatment group. The comparison for a 
difference in feed intake is made between mean feed intake three days prior to injection and three days 
post injection. The arrow in each figure represents the point of injection. Significantly lower feed 
intake in leptin treated group, Experiment two.  
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3.2 Growth 
Somatic growth of the fish was expressed as the thermal growth coefficient (TGC) 
ratio (Figure 3). In Experiment one (Figure 3A) no significant difference in growth 
was observed between treatments and control, (Figure 3A; p>0.05 ANOVA). In 
Experiment two a significantly decreased growth ratio was found in the leptin treated 
group (Figure 3B; p=0.032 ANOVA), however no significant difference in growth 
was found in the ghrelin treated group (Figure 3B; p=0.971 ANOVA).  
 
Figure 3 Mean TGC ratio of Atlantic salmon. A=Experiment one, control n=6, leptin n=3, ghrelin n=5. 
B=Experiment two, control n=4, leptin n=6, ghrelin n=5. Mean ± SE represented by bars.  
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3.3 Plasma Metabolites 
There were no significant differences in plasma metabolites between treatments in 
Experiment one (Table 3; p>0.05 ANOVA). A significantly lower concentration of 
circulating D-3-Hydroxybutyrate was measured in the ghrelin treated group in 
Experiment two (Table 4; p=0.024 ANOVA). A similar trend in D-3-
Hydroxybutyrate concentration was also observed in the ghrelin treated group in 
Experiment one and the difference could be considered significant (Table 3; p=0.053 
ANOVA)  
 
Table 3 Mean Plasma metabolites in mmol/L, Experiment one. Control n=6, Leptin n=3, Ghrelin n=5. 
Mean ± SE. No significant differences were observed.  
Plasma metabolite concentrations Experiment one 
Metabolite Control Leptin Ghrelin 
FFA 0.21 ± 0.01 0.19 ± 0.03 0.17 ± 0.00 
Triglycerides 1.46 ± 0.14 1.71 ± 0.06 1.61 ± 0.13 
Glucose 5.14 ± 0.26 5.12 ± 0.26 5.62 ± 0.26 
Lactate 1.79 ± 0.17 1.91 ± 0.14 1.68 ± 0.13 
D-3-Hydroxybutyrate 0.065 ± 0.007 0.094 ± 0.012 0.053 ± 0.011 
 
Table 4 Mean Plasma metabolites in mmol/L, Experiment two. Control n=4, Leptin n=6, Ghrelin n=5. 
Mean ± SE. Bold superscript denotes a significant difference in D-3-Hydroxybutyrate levels in the 
ghrelin treated group.  
Plasma metabolite concentrations Experiment two 
Metabolite Control Leptin Ghrelin 
FFA 0.13 ± 0.01 0.12 ± 0.00 0.12 ± 0.01 
Triglycerides 1.65 ± 0.28 1.52 ± 0.18 1.68 ± 0.28 
Glucose 5.43 ± 0.44 5.47 ± 0.18 5.43 ± 0.31 
Lactate 1.81 ± 0.19 2.12 ± 0.20 1.93 ± 0.19 
D-3-Hydroxybutyrate 0.096 ± 0.015 0.101 ± 0.018 0.054 ± 0.005 
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3.4 Plasma ghrelin 
A significantly higher concentration of circulating ghrelin was found in the ghrelin 
treated group in Experiment one (Figure 4A; p=0.013 ANOVA). No significant 
difference was found between leptin and control in Experiment one, or between 
injected groups and control in Experiment two (Figure 4B; p>0.05 ANOVA). 
 
Figure 4 Mean plasma ghrelin in pg/ml. A=Experiment one. Control n=6, leptin n=3, ghrelin n=5. 
B=Experiment two. Control n=4, leptin n=6, ghrelin n=5. Mean ± SE represented by bars. The letter b 
denotes a significant difference from control marked a.  
  
 
 
 
  41 
 
3.5 Gene expression 
3.5.1 Leptin expression in liver and stomach 
No significant difference in the expression of LEP in liver and LEP receptors in liver 
and stomach between treatment and control were found in Experiment one (Figure 
5; p>0.05 ANOVA). LEPR1 appeared to be highly expressed in liver in the leptin 
treated group (Figure 5C and Figure 6C), but the expression is not significantly 
different from the control. LEPR2 appears to be highly expressed in the stomach 
tissue of the ghrelin treated group (Figure 5D and Figure 6D), however expression is 
not significantly higher than in the control group. 
 
 
Figure 5 Mean relative expression of leptin and leptin receptors in liver and leptin receptors in 
stomach, Experiment one. Control n=6, leptin n=3, ghrelin n=5. Mean ± SE represented by bars. There 
were no significant differences between treatment groups and control group. 
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Expression of LEPA1 was significantly highler in the liver of the leptin treated group 
compared to control (Figure 6A; p=0.021 ANOVA). Expression of LEPA2 was also 
significantly higher in the liver of both the leptin and ghrelin treated group compared 
to control (Figure 6B; 0.005 ANOVA, p=0.019 ANOVA). No significant difference 
in the expression of LEPR1 and LEPR2 compared to control was found in liver or 
stomach in Experiment two (Figure 6; p>0.05 ANOVA)  
 
 
 
Figure 6 Mean relative expression of leptin and leptin receptors in liver and leptin receptors in 
stomach, Experiment two. Control n=4, leptin n=6, ghrelin n=5. Mean ± SE represented by bars. Letter 
b denotes a significant difference from the control marked a.  
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3.5.2 Ghrelin expression in liver and GH and IGF expression in stomach 
The expression of GHRL1A and GHRL1B was significantly higher in the stomach 
tissue of the ghrelin treated group (Figure 7E; p=0.027 ANOVA and Figure 7F; 
p=0.016 ANOVA). No significant difference in the expression of GHR1, GHR2, 
IGF1 and IGF2 compared to control in liver or stomach tissue were found in 
Experiment one (Figure 7; p>0.05 ANOVA) 
 
 
Figure 7 Mean relative expression of growth hormone and Insulin-like growth factor in liver and 
ghrelin in stomach, Experiment one. Control n=6, leptin n=3, ghrelin n=5. Mean ± SE represented by 
bars. The letter b denotes a significant difference from control marked a.  
 
No significant difference in the expression of GHR1, GHR2, IGF1, and IGF2 in liver 
and GHRL1A and GHRL1B in stomach were found in Experiment two (Figure 8; 
p>0.05 one way ANOVA). 
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Figure 8 Mean relative gene expression of growth hormone and insulin –like growth factor in liver and 
ghrelin in stomach, Experiment two. Control n=4, leptin n=6, ghrelin n=5. Mean ± SE represented by 
bars. There were no significant differences between treatment groups and control group. 
 
 
 
 
 
 
 
  45 
3.5.3 Neuropeptides 
3.5.3.1 Anorexigenic Neuropeptides 
No significant differences in the expression of neuropeptides; POMCA1, POMCA2, 
POMCA2S, POMCB, CART, PYY, LEPR1, LEPR2 were found in Experiment one 
(Figure 9; p>0.05 ANOVA). 
 
Figure 9 Mean relative gene expression of anorexigenic neuropeptides in brain, Experiment one. 
Control n=5, leptin n=3, ghrelin n=5. Mean ± SE represented by bars. There were no significant 
differences between treatment groups and control group.  
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POMCA1 and POMCA2 appear to be up regulated in the leptin treated group 
compared to control (Figure 10A; p=0.067 Mann-Whitney U and Figure 10B; 
p=0.067 Mann-Whitney U). PYY was down regulated in the leptin treated group 
(Figure 10F; p=0.038 Mann-Whitney U) and the ghrelin treated group (Figure 10F; 
p=0.016 Mann-Whitney U). No significant differences in the expression of 
neuropeptides; POMCA2S, POMCB, CART, LEPR1 and LEPR2, were found in 
Experiment two (Figure 10; p>0.05 ANOVA). 
Figure 10 Mean relative gene expression of anorexigenic neuropeptides in the brain, Experiment two. 
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Control n=4, leptin n=6, ghrelin n=5. Mean ± SE represented by bars. The letter b denotes a significant 
difference from control marked a.  
 
No significant difference in the expression of CCKL and CCKN expression were 
found in the leptin treated group compared to the control in Experiment one (Figure 
11; p>0.05 Mann-Whitney U, p>0.05 ANOVA). Expression of CCKL and CCKN in 
the ghrelin treated group was significantly lower than in the control, indicating a 
down regulation of CCKL and CCKN in the ghrelin treated group in Experiment one 
(Figure 11; p=0.004 ANOVA, p=0.048 ANOVA). 
 
Figure 11 Mean relative expression of neuropeptides Cholecystokinin-L and Cholecystokinin-N in the 
brain, Experiment one. Control n=5, leptin n=3, ghrelin n=5. Mean ± SE represented by bars. Letter b 
denotes a significant difference from control marked a. Treatment group marked a denotes no 
significant difference from control also marked a.  
 
No significant difference in the expression of CCKL and CCKN were found between 
treatment groups and control in Experiment two (Figure 12; p>0.05 Mann-Whitney 
U). 
 
Figure 12 Mean relative expression of neuropeptides Cholecystokinin-L and Cholecystokinin-N in the 
brain, Experiment two. Control n=4, leptin n=6, ghrelin n=5. Mean ± SE represented by bars. No 
significant differences between treatment and control. 
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3.5.3.2 Orexigenic Neuropeptides 
Expression of AGRP1 was significantly higher in the leptin treated group than the 
control, indicating an upregulation of AGRP1 (Figure 13A; p=0.047 ANOVA). No 
significant differences in the expression of AGRP2, NPY and GHRLR were found in 
the leptin or ghrelin treated groups compared to the control (Figure 13B, C, D 
p>0.05).  
 
Figure 13 Mean relative gene expression of orexigenic neuropeptides in the brain. Control n=5, leptin 
n=3, ghrelin n=5. Mean ± SE represented by bars. The letter b denotes a significant difference from 
control marked a.  
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No significant differences in the expression of AGRP1, AGRP2, NPY or GHRLR 
where found in the leptin or ghrelin treated groups compared to the control in 
Experiment two (Figure 14A,B,C,D p>0.05 ANOVA).  
 
Figure 14 Mean relative gene expression of orexigenic neuropeptides in the brain. Control n=4, leptin 
n=6, ghrelin n=5. Mean ± SE represented by bars. No significant difference between treatment and 
control. 
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4. Discussion 
 
4.1 Feed intake 
This is the first report that demonstrates by direct measurement that rsLEPA1 injected 
IP leads to a reduced feed-intake in Atlantic salmon. This was observed in 
Experiment two where there was a significant reduction in feed intake in rsLEPA1 
treated Atlantic salmon while the sham treated control had no change in feed intake. 
The data in Experiment one had trends suggesting similar results, but these were not 
significant. Murashita et al., (2008) found a rapid suppression of feed intake post 
rsLEPA1 injection indicating a strong short term anorexic effect, so one could expect 
to see the greatest reduction in feed intake the day after injection, which is not the 
case in Experiment one in this study, However Murashita et al., (2008) injected 
recombinant rainbow trout leptin in phosphate buffered saline which may be released 
quicker than a hormone in vegetable oil. Although the results were not the same in 
Experiment one and two the results in Experiment two show that recombinant 
rsLEPA1 injected IP causes a significant reduction in feed intake in Atlantic salmon 
(Appendix 1). These results support the findings that recombinant LEP treatment 
reduces feed intake in teleosts such as rainbow trout (Murashita et al., 2008), goldfish 
(Vivas et al., 2011) and Atlantic salmon (Murashita et al., 2011) and suggest that LEP 
treatment in salmon produces a reduction in feed intake similar to that observed in 
higher vertebrates such as mammals; pigs Sus spp. (Barb et al., 1998), rats Rattus spp. 
(Watzler et al., 2004) and birds; chickens Gallus spp. (Denbow et al., 2000), great tits 
Parus major (Lõhmus et al., 2003).  
 
Fish treated with ghrelin showed no alteration in feed intake compared to the control 
group (Appendix 1). These findings are contradictory to other studies in teleosts, as 
rainbow trout injections and implants have previously been found to both decrease 
food intake (Kling et al., 2012) and increase feed intake in goldfish (Matsuda et al., 
2006). Ghrelin has also been found to increase feed intake in higher vertebrates such 
as humans (Wren et al., 2001) and rats (Locke et al., 1995). There does not seem to 
be such a clear relationship between the injection of purified rainbow trout and an 
increase in feed intake in Atlantic salmon. This may be due to the fact that rainbow 
trout ghrelin was administered to Atlantic salmon in this study, thus species specific 
ghrelin may be required to produce any effects on appetite. Ghrelin injected IP in 
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goldfish at 10 pmol/g BW produced an increase in feed intake (Matsuda et al., 2006) 
and rainbow trout ghrelin injected with 0.05 or 5 nmol/kg− 1 IP (Jönsson et al., 2007) 
produced no increase in feed intake. It is unlikely that the dose set in this study was 
too low as Jönsson et al., (2007) achieved similar results with lower dosages. It is 
possible that the effect of ghrelin on food intake varies with the route of 
administration, source of hormone, species and dose (Jönsson et al., 2007) 
 
4.2 Growth 
The somatic growth of fish was significantly reduced in the LEP injected group in 
Experiment two. The growth rate appeared to be reduced in Experiment one but the 
reduction was not significantly compared to the control. The reduced growth rate of 
LEP treated fish in Experiment two is likely a consequence of the reduced feed intake 
that was also observed in Experiment two, which further supports that ssLEPA1 
causes a reduction in appetite and consequently reduces growth in Atlantic salmon. 
These results are supported by Murashita et al., (2011) who also found that 
recombinant ssLEPA1 administered IP significantly reduced the growth rate of 
Atlantic salmon. The reduction in growth observed in this study suggests that the role 
of LEP is comparable to that in other teleosts such as rainbow trout (Murashita et al., 
2008) and fine flounder Paralichthys adspersus and in higher vertebrates, such as 
humans (Dardeno et al., 2010, Lee et al., 2002), pigs (Barb et al., 2001, Ramsay et 
al., 2004) and mice (Leinninger et al., 2009).  
 
Fish in the ghrelin injected group showed no significant difference in growth 
compared to the control, this could be expected as ghrelin treated fish showed no 
alteration in feed intake. These results are in contrast to other studies as Jönsson et al., 
(2007) found that long-term peripheral ghrelin treatment of rainbow trout reduced 
feed intake, which was reflected in a ghrelin-inudced drecrease in weight growth rate. 
However Jönsson et al., (2007) utilized native rainbow trout ghrelin in their study and 
ghrelin may well have species specific effects. Ghrelin is generally considered to 
cause growth through the stimulation of GH secretion from the pituitary in mammals, 
birds, amphibians and teleosts (Kaiya et al., 2013). Ghrelin in Atlantic salmon may 
not function in a manner comparable to other species, but the evidence drawn from 
this study is not enough to make any conclusions.  
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4.3. IP injection – time and release  
Leptin and ghrelin both form part of a feedback regulated loops, so one could expect 
that injecting these hormones would increase the level of the hormone in blood 
plasma. The levels of these hormones in plasma will in turn feedback to central 
systems possibly altering the regulation of appetite and affecting other pathways 
involved in appetite regulation. Previously, the method of administering peptide or 
steroid hormones emulsified in vegetable oil has worked well in terms of release and 
uptake in circulation in Atlantic salmon (McCormick, 1996; McCormick et al., 2008; 
Specker et al., 1994). This method of administrating hormones causes extended 
elevation of the hormone in plasma, for approx. 1-2 weeks depending on water 
temperature and can be considered the best method for administrating hormones in 
Atlantic salmon (Nilsen, T.O personal communication). Injecting hormones in an oil 
emulsion makes endogenous time of release difficult to determine. However it has 
been shown that by administering a certain volume of fat emulsion per gram of fish 
one can obtain a pellet of relatively the same size in the abdomen of the injected fish, 
therefore one can argue that the time of release should be the same in any given 
individual (Nilsen, T.O. personal communication). Variation can always occur but by 
measuring plasma levels of the given hormone one can find out if the hormone has 
been released at equally, in this study the different doses were set for each individual 
so one should expect to see different levels of hormone in plasma.  
 
4.4 Plasma metabolites  
The concentration of plasma metabolites FFA, Triglycerides, Glucose, Lactate and D-
3-Hydroxybutyrate were similar in the LEP treated group and control. These results 
are comparable to those found in mammals as Tanida et al., (2000) found that LEP 
injected into white adipose tissue (WAT) did not cause any change in the 
concentration of insulin, glucose and lactate in in Rattus spp. LEP may not influence 
neuroendocrine regulation through this route, but rather directly through sensors in 
afferent nerves (Tanida et al., 2000). In the GHRL treated group no difference in the 
concentration of FFA, triglycerides, glucose or lactate where found compared to the 
control. However the concentration of D-3-hydroxybutyrate in plasma was 
significantly lower in the GHRL treated group in Experiment one and two.  
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Hydroxybutyrate is a ketone body, which is produced in the liver mainly from the 
oxidation of fatty acids and is exported to surrounding tissues as a source of energy 
(Guthrie and Jordan, 1972). Normal ketosis can indicate that lipid metabolism has 
been activated and the pathway of lipid degradation is intact, and is often found 
during fasting, prolonged exercise or a high fat diet (Galan et al., 2001). As the 
concentration of D-3-hydroxybutyrate was significantly lower in the GHRL treated 
group, in both experiments it is likely that purified rainbow trout ghrelin somehow 
influences ketone metabolism in Atlantic salmon. As D-3-hydroxybutyrate is 
synthesized under nutritional states where carbohydrates and lipid oxidation are 
unbalanced (Willmott et al., 2005) these results suggest that the GHRL treated fish do 
not have a reduced glucose or lipid metabolism, but a reduced lipid catabolism. In 
humans ghrelin has an effect on fatty acid release and ketone body formation and 
ghrelin infusions have been coupled with a significant increase in 3-hydroxybutyrate 
ketone bodies in plasma (Huda et al., 2011), these findings could suggest that ghrelin 
has an alternative role in the stimulation of ketosis in teleosts.  
 
4.5 Metabolites and Stress 
Handling and physical disturbances can cause stress in fish (Barton and Iwama, 1991; 
Evans and Clairborne, 2006). In response to the stressor the fish will undergo 
biochemical and physiological changes in order to cope with the stress factor. The 
initial response includes a neuroendocrine response that includes a release of 
catecholamines and cortisol into circulation (Evans and Clairborne, 2006). A rise in 
cortisol following chronic stress has been linked to higher plasma glucose and energy 
mobilisation (McCormick et al., 1998), thus changes in plasma glucose concentration 
have been used as an indicator of a metabolic response to stress in fish. Elevated 
cortisol levels that occur due to stress may reduce growth and administration of 
cortisol reduces growth in Orynchus mykiss and channel catfish Ictalurus punctatus. 
Unstressed sockeye salmon Oncorhynchus nerka have plasma glucose concentrations 
of 110 mg/ml in males and 103 mg/ml in females, when stressed the concentrations 
gradually increase to 150 mg/ml and 142 mg/ml after 15-30 minutes of stress 
(Kubokawa et al., 1999). In the current study glucose concentrations in the LEP 
injected group were not elevated compared to the control in Experiment one or two. 
Throughout treatment and control groups plasma glucose levels were below 1 mg/ml 
in both Experiment one and Experiment two. The low and steady glucose 
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concentrations found in this study in control, rsLEPA1 and GHRL1 treated groups 
may indicate that the fish were not stressed by the experimental method and as such 
validate that the method used for sedating the fish in the tank before anesthesia and 
injection is not stressful to salmon. This is also verified by the fact that the salmon 
started to eat within a few hours after they were returned to the tanks post injection. 
Normal recovery back to pre-handling feeding levels takes days in Atlantic salmon. 
As a decreased growth rate was observed in the LEP treated group in Experiment two 
but the plasma glucose concentrations did not differ between treatment group and 
control and were not elevated it is likely that decreased growth was not caused by 
stress and elevated glucose levels, but by the recombinant rsLEPA1 injection. 
 
4.6 Plasma Ghrelin  
Elevated levels of plasma ghrelin where found in the ghrelin injected fish in 
Experiment one, but not Experiment two. Fish that have been injected with ghrelin 
could be expected to show elevated levels of plasma ghrelin. In Experiment one 
GHRL1A and GHRL1B were upregulated in the stomach tissue of ghrelin injected 
fish, however these genes were not upregulated in Experiment two. As ghrelin is 
primarily produced in endocrine cells in the gastric glands or the mucosoal folds in 
the stomach the elevated concentration of ghrelin in blood plasma is likely related to 
elevated levels of ghrelin mRNA found at the main site of production. As GHRL1A 
and GHRL1B were not upregulated in the stomach tissue of ghrelin injected fish in 
Experiment two and no change in ghrelin plasma concentration levels where found 
further suggests that expression of ghrelin in the stomach and plasma ghrelin levels 
may be related. Matsuda et al., (2006) suggest that the ghrelin signal that leads to 
increased food intake in goldfish is mediated through the afferent vagus nerve rather 
than the bloodstream, however we found no difference in feed intake between ghrelin 
injected fish and the control. The results in this study show no link between 
expression of ghrelin in stomach, elevated levels of plasma ghrelin and any short-term 
change in feed intake. However Hevrøy et al., (2012) found reduced plasma ghrelin 
and stomach ghrelin mRNA levels in Atlantic salmon exhibiting voluntary fasting at 
elevated temperatures. Murashita et al., (2009) also found that mRNA levels of 
GHRL1 but not GHRL2 increased after 6 days fasting in Atlantic salmon. It is 
possible that elevated levels of ghrelin in plasma may be related to feed intake on a 
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longer time scale rather than short term. However the increased levels of ghrelin in 
plasma observed in this study may be due to the injection of rtGHRL. 
 
4.7 Gene expression 
 
4.7.1 Recombinant IP administered leptin and neuropeptide expression  
This study reports significantly higher expression of LEPA1 and LEPA2 in the liver of 
rsLEPA1-injected fish compared to control. In mammals leptin is expressed mainly 
by adipose tissue which is reflected by the fact that mammals deposit and store energy 
in adipose tissue. Adipose tissue and plasma leptin concentrations are dependent on 
the amount of energy stored as fat as well as the energy balance, this means that leptin 
levels are higher in obese individuals and increase with overfeeding (Ahima and Flier, 
2000; Ahima and Osei, 2004), thus leptin functions as an endocrine indicator of 
adipose energy reserves (Won et al., 2013) Many teleost fish utilize the liver as a 
major lipid storage site and the liver is also considered a major site of leptin 
production as LEP genes have been found to be highly expressed in the livers of 
pufferfish (Kurokawa et al., 2005), striped bass (Won et al., 2012) and yellow catfish 
Gong et al., (2013). On the other hand fatty fish such as Atlantic salmon mainly 
deposit and store energy in muscle tissue and visceral adipose tissue, which is to some 
extent reflected by a high expression of LEPA1 in muscle tissue. In contrast to other 
teleosts LEP expression is lower in tissues containing more adipocytes, visceral 
adipose tissue for example consists almost entirely of adipocytes but displays a much 
lower expression of LEP than muscle and liver tissue (Rønnestad et al., 2010). 
Whether leptin is produced or secreted in relation to the hepatic lipid content or 
adipose content of fish is still unknown (Won et al., 2012). Although Atlantic salmon 
utilise the liver to minor extent for energy storage, hepatic expression of LEPA1 is 
significant and comparable to the expression found in white muscle (Rønnestad et al., 
2010). Previous research has shown that pufferfish hepatocytes contain abundant oil 
droplets and LEP has been detected in hepatocytes (Kurokawa et al., 2005), indicating 
that liver expression of LEP is linked to energy metabolism of the hepatocytes. Our 
findings further support the hypothesis that expression of LEP in the liver is linked to 
metabolism.  
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Two experiments were performed in this study; in experiment one no significant 
reductions in feed intake or growth rate were found and LEPA1 and LEPA2 
expression in liver were not affected. Plasma levels of leptin were not measured as 
part of this study so it is difficult to speculate on how leptin plasma levels were 
affected by exogenous administration of LEPA1, however we can assume that the 
levels were altered as POMC isoforms were upregulated at a central level in 
Experiment two and that these possibly form part of an appetite regulating pathway as 
feed intake was reduced. One might expect that LEPA1 mRNA levels would be 
reduced at the sites of production such as in the liver due to external administration of 
LEPA1 however in Experiment two a significant upregulation of LEPA1 and LEPA2 
in liver was found, along with a reduction in feed intake and lower growth rate.  
These results suggest that LEP expression in the liver could be linked to the 
expression of POMC at a central level and short term changes in feed intake and 
metabolism. Previously Ronnestad et al., (2010) found that LEPA2 mRNA levels in 
the liver were higher in a group of Atlantic salmon with reduced rations over an 
extended period of time, this study shows that LEPA2 expression in liver may also be 
involved in short term changes in appetite in a manner comparable to that found in 
higher vertebrates. Our findings are also supported by Kullgren et al., (2013) who 
found that leptin acted as a signaling factor contributing to reduced food intake in 
Atlantic salmon.  
 
We found that administration of rsLEPA1 did not affect mRNA expression of NPY, 
AGRP isoforms, or CART in brain tissue in Experiment two, which is supported by 
Murashita et al., (2011) who also found that administration of rsLEPA1 did not affect 
NPY, AGRP and CART mRNA expression in the brain. However in Experiment one 
we found that rsLEPA1 injected fish had upregulated mRNA expression of AGRP1 in 
the brain. Leptin inhibits the NPY/AGRP1 neuron from releasing orexigenic peptides, 
the fact that AGRP1 is upregulated in Experiment one suggests that injected leptin 
may not be in circulation which is supported by the fact that feed intake is neither 
decreased, as one could expect in fish with increased leptin levels, or increased as one 
could expect with increased expression of AGRP1. Plasma leptin levels were not 
measured as part of this study, so no conclusions can be made based on plasma levels 
of leptin.   
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POMC may play a more important role in the short-term leptin-signaling pathway and 
could function independently of AGRP/NPY expressing neurons in Atlantic salmon as 
when the expression of POMCA1 and POMCA2 is upregulated a significant reduction 
in feed intake is also observed. The results presented in this study supports those of 
Murashita et al., (2011), who also found increased expression of POMCA1 in Atlantic 
salmon administered rsLEPA1. Previously IP injections of rsLEPA1 reduced short-
term food intake with increased expression of POMCA1 and POMCA2 and decreased 
expression of NPY in rainbow trout, meanwhile Atlantic salmon fasted for 6 days 
showed no significant change in the expression of NPY (Murashita et al., 2011; 
Murashita et al., 2009). Valen et al., (2011) also found that POMCA1 and POMCB 
were upregulated within 3 hours of feeding, which supports that these neuropeptides 
are involved in a short-term appetite regulating pathway. In relation to the 
upregulation of POMCA1 and POMCA2 it is important to note that the fish were fed 
one meal in the morning at the 09:00 and slaughtered at within 4 hours of the meal in 
both experiments, we found that POMC-type genes were only upregulated in 
Experiment two in which LEP-type genes were also upregulated and feed intake was 
reduced.  
 
We found that PYY expression in the brain was downregulated in leptin injected fish 
in Experiment two. PYY is associated with a reduction of feed intake in mammals 
(Cummings and Overduin, 2007). Previous studies of Atlantic salmon show that 
fasting and feeding have minimal effects on PYY mRNA expression in the brain 
(Murashita et al., 2011; Valen et al., 2011). However Valen et al., (2011) did find 
postprandial changes in PYY expression in the GI tract, and suggest that PYY responds 
differently to feed intake depending on peripheral or central expression, but that PYY 
plays a minor role in the central control of short-term food intake in Atlantic salmon. 
These results are in contrast to the findings in this study where PYY is downregulated 
in fish with a significant reduction in feed intake and upregulation of hepatic LEPA1 
and LEPA2 and POMC isoforms. PYY concentration in plasma increases after feeding 
and decreases during fasting in mammals (Murphy and Bloom, 2006), our findings 
are to some extent in line with the mammalian model as the apparent rsLEPA1 
induced reduction in feed intake could be considered involuntary fasting and thus may 
be involved in the reduced levels of PYY mRNA observed in the brain. It is possible 
that leptin-signaling pathway affects the expression of PYY at a central level. 
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4.7.2 Purified IP administered ghrelin and neuropeptide expression  
This study reports significantly higher mRNA expression of GHRL1A and GHRLIB in 
the stomach of rtGHRL-injected fish compared to control. Two experiments were 
performed and the expression of GHRL1A and GHRLIB was only upregulated in the 
experiment in which plasma ghrelin levels were found to be elevated. Significant 
changes in the mRNA expression of neuropeptides associated with orexigenic 
functions AGRP1, AGRP2, NPY and receptor GHRL1R were not found in rtGHRL 
treated fish. However mRNA expression of the anorexigenic peptides CCK and 
CCKL was significantly lower than the control in Experiment one and also appeared 
to be lower in Experiment two, although not significantly.  
 
Previously Gao et al., 2012 found that ghrelin supplemented in the diet of grouper 
Epinephelus coioides caused an increase in the expression of hypothalamic NPY 
mRNA and also an increase in feed intake and weight. Furthermore Terova et al., 
(2008) found mRNA levels of ghrelin in stomach were upregulated during negative 
energy balance, such as starvation, and downregulated during positive energy balance, 
such as refeeding and suggest that ghrelin has an orexigenic role in the regulation of 
food intake in sea bass. In salmonids the possible orexigenic function of ghrelin is not 
so clear. mRNA levels of GHRL1 but not GHRL2 have been found to increase during 
fasting in Atlantic salmon (Murashita et al., 2009) indicating a possible orexigenic 
role in Atlantic salmon (Kaiya et al., 2011). However injections of rtGHRL have 
decreased feed intake in rainbow trout and long-term peripheral IP implants of 
rtGHRL have also reduced daily feed intake compared to controls (Jönsson et al., 
2010). Furthermore Jönsson et al., (2010) suggest that ghrelin may act on the GHS-R 
in the CNS in rainbow trout as an anorexigenic hormone and that elevated periheral 
ghrelin leads to decreased feed intake in the long term (14 days). The inhibitory 
mechanism of ghrelin on food intake described in rainbow trout is similar to that 
demonstrated in the chicken (Kaiya et al., 2011).  
 
As mentioned previously ghrelin is produced primarily in the stomach in response to 
hunger and circulates in the blood in mammals. Plasma ghrelin levels increase during 
fasting and decrease after ingesting glucose and lipid, but not protein. The efferent 
vagus nerve contributes to the fasting-induced increase in ghrelin secretion. Ghrelin 
secreted by the stomach stimulates the afferent vagus nerve and promotes feed intake. 
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The vagal circuit between the central nervous system and stomach has a crucial role 
in regulating plasma plasma ghrelin levels (Nonogaki, 2007). Thus it could be 
expected that the injected rtGHRL would cause an elevation of ghrelin plasma levels 
as the fish assimilate the cholesterol pellet formed by an IP injection. Based on this 
feedback mechanism one might expect to see a reduction in the fishes own production 
of ghrelin in the stomach and a downregulation of GHRL1A and GHRLIB in stomach 
tissue assuming that the fish did not have a hungersignal four hours after feeding at 
the point of sampling. Hevrøy et al., (2012) found a reduced plasma ghrelin 
concentration and reduced GHRL1 expression in stomach of Atlantic salmon kept at 
19° C after 21 days and suggest this may be due to long-term neuropeptide signaling. 
It is possible that the potential orexigenic or anorexigenic effects of elevated plasma 
ghrelin only become evident after a longer period of time, bearing in mind that fish in 
this study were sampled after four days in Experiment one and five days in 
Experiment two. 
 
Peripheral ghrelin can interfere with the CCK related mechanism in the regulation of 
satiety and food intake but also with other neuropeptides involved in homeostatic 
regulation of energy intake and expenditure (Kobelt et al., 2005). Gastrointestinal 
peptides such as CCK can suppress ghrelin secretion, however the effects may be 
indirect and/or have been difficult to reproduce and the physiological relevance 
remains unclear (Engelstoft et al., 2013). Known signals inhibiting ghrelin secretion 
are mainly endocrine and paracrine, known stimulatory signals are mainly neuronal 
(Engelstoft et al., 2013). Sympathetic nerve and vagal stimulation increase ghrelin 
secretion. Sympathetic stimulation most likely occurs directly at the ghrelin cell via 
beta1 adrenergic receptors. Vagal stimulation depends on colinergic muscarinic 
mechanisms, but whether this effect is direct or indirect is unclear (Engelstoft et al., 
2013). Inhibition of these pathways prevents fasting-induced elevation of plasma 
ghrelin (Engelstoft et al., 2013) 
  
CCK exists in the endocrine cells of the GI tract and within the central and peripheral 
nervous system (Lin et al., 2000). CCK acts as a satiation factor at the levels of the 
gut and centrally in specific brain regions in mammals (Lin et al., 2000). In goldfish 
IP and ICV injections of CCK8 acutely suppresses food intake, supporting that CCK 
acts as a satiety factor in fish. Furthermore Peyon et al., (1999) had previously found 
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an acute increase in CCK mRNA levels in the olfactory bulbs, telencephalon-preoptic 
region, hypothalamus, and posterior brain 120 minutes after a meal. This evidence 
supports that CCK synthesis and release occur following a meal (Lin et al., 2000). 
However Nguyen et al., 2013 did not find any data that could support brain CCK 
acting as a satiety signal in Cobia Rachycentron canadum but these fish were sampled 
only once 15 minutes after a meal and changes in CCK expression may take longer to 
occur. There is evidence that CCK has a similar anorexigenic function in salmonids; 
Jönsson et al., (2006) found a postprandial elevation of plasma CCK levels most 
evident after 4 and 6 hours in rainbow trout. Their results indicated that the endocrine 
release of gastrointestinal CCK was increased during feeding. CCK regulation also 
occurs at a central level postprandially, Valen et al., (2011) found that CCKL 
expression in the brain was higher than in unfed controls 0.5, 1.5, 3, 6, 9 and 12 hours 
post feeding in Atlantic salmon. However Murashita et al., (2009) found no change in 
the expression of CCK isoforms in the GI tract and brain of Atlantic salmon, but these 
fish were sampled after 6 days of fasting, and according to Valen et al., (2011) this is 
due to CCK acting within a shorter timeframe. In immature rainbow trout oral 
administration of CCK antagonists increases feed intake in immature rainbow trout 
(Gelineau and Boujard, 2001) 
 
In mammals the satiation effect of CCK depends on signaling via the vagus nerve and 
the vagal afferent-dependent mechanisms may be involved in peripheral ghrelin-
induced increase in food intake (Kobelt et al., 2005). Furthermore Kobelt et al., 2005 
claim there could be an antagonistic interaction between ghrelin and CCK to regulate 
food intake. Kobelt et al., 2005 found that ghrelin injected IP exerted an orexigenic 
effect in freely fed rats. However, in rats injected with both ghrelin and CCK feed 
intake was reduced. They conclude that the stimulation of food intake and neuronal 
activity in the ARC induced by ghrelin administered intraperitoneally is abolished by 
intraperitoneal CCK.  
 
In this study CCKL and CCKN were downregulated in brain tissue of rtGHRL treated 
fish in Experiment one. All the fish in this study were sampled four hours post 
feeding and according to the mentioned studies one might expect to see an 
upregulation of CCK, however no changes in mRNA expression of CCKL and CCKN 
were found in control or treatment groups except for in the ghrelin treated fish which 
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also had elevated plasma ghrelin levels and upregulated expression GHRL1A and 
GHRLIB in stomach tissue. It is possible that there could be a similar antagonistic 
relationship between ghrelin and CCK as described in rats by Kobelt et al., 2005. 
However the downregulation of CCK isoforms in brain, upregulation of GHRL1A and 
GHRLIB in stomach and elevated plasma ghrelin levels did not coincide with any 
short term change in feed intake in this experiment. The data found in this study 
indicates that plasma ghrelin could have an effect on postprandial changes in CCK 
expression at a central level, which in turn could influence feeding regulation as CCK 
is generally found to increase postprandially and have inhibitory effects on further 
food intake in fish, although changes in appetite were not found in ghrelin injected 
fish in this experiment.  
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5. Conclusion 
In summary the present study reports that administered rsLEPA1 causes a significant 
reduction in feed intake and SGR in Atlantic salmon. POMC isoforms seem to be  
involved in the leptin-signaling pathway as mRNA expression of POMCA1 and 
POMCA2 is only upregulated when a significant reduction in feed intake is also 
observed in rsLEPA1 administered Atlantic salmon. Hepatic LEPA1 and LEPA2 
mRNA expression was upregulated compared to control in rsLEPA1 administered 
fish which also showed a reduction in feed intake and growth linking hepatic 
expression of LEP isoforms to metabolism. PYY mRNA expression was 
downregulated in brain tissue in fish with a significant reduction in feed intake and 
could be involved in the leptin-signaling pathway at a central level.  
 
Significantly higher mRNA expression of GHRL1A and GHRLIB was found in the 
stomach of rtGHRL-injected fish compared to control, and mRNA expression was 
only upregulated when plasma ghrelin levels were found to be elevated. Rainbow 
trout GHRL1 administered IP was not found to affect feed intake in Atlantic salmon 
in this study. CCKL and CCKN mRNA expression was downregulated in the brain 
tissue of rtGHRL treated fish which also showed elevated plasma ghrelin levels. D-3-
hydroxybutyrate levels in plasma were elevated in GHRL1 administered fish 
suggesting that ghrelin has a role in the regulation of ketosis in Atlantic salmon.  
 
The method incorporating an individual based system and IP administration of 
hormones was validated. Low and steady glucose and lactate concentrations were 
found in both control and hormone administered fish, indicating that the fish were not 
stressed. Furthermore salmon started to eat within hours of being returned to the 
tanks.   
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Appendix 1 
 
Table 1 Feed (g) eaten per fish per day Experiment 1 pre and post injection 
 
Table 2 Feed (g) eaten per fish per day Experiment 2 pre and post injection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
